The role of AT1 angiotensin receptor activation in the pathogenesis of preeclampsia

T. P. Doering, N. A. Haller, M. A. Montgomery, E. J. Freeman, M. P. Hopkins, George Saade

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

OBJECTIVES: Preeclampsia is characterized by an increase in vascular tone associated with reduced uteroplacental flow. The nature of hypertension arising in pregnancy suggests that the abnormal increase in blood pressure is dependent on some humoral factor that mediates vasospasm. There is evidence that preeclampsia results from a breakdown in the balance between vasodilators such as prostacyclin and prostaglandin E2 and nitric oxide and the vasoconstrictors angiotensin II, thromboxane A2, serotonin, and endothelin. Furthermore, vascular reactivity to angiotensin II is greatly enhanced in preeclampsia as opposed to normal pregnancies. The increased vascular tone and the enhanced thromboxane production noted in preeclampsia may be mediated by the increased sensitivity to angiotensin II because angiotensin II coupled to an AT1 receptor is a potent vasoconstrictor and stimulates the accumulation of free arachidonic acid, the precursor of thromboxane and the prostaglandins. STUDY DESIGN: We used a rat model that has been shown to express the relevant clinical features of human preeclampsia to investigate the involvement of the AT1 angiotensin receptor in this pathologic condition. Pregnant rats were divided into three groups that were either infused with saline or endotoxin on the 14th day of pregnancy. One of the endotoxin-infused groups was further treated with the AT1-selective antagonist losartan from day 11 until day 19 of pregnancy. RESULTS: Perinatal outcome, blood pressure, and urine protein were monitored for each group. We observed that endotoxin infusion resulted in a decrease in pup weight and number of pups and caused an increase in mean arterial pressure as well as increased proteinuria when compared with saline solution- infused animals. In contrast, endotoxin-infused rats receiving losartan exhibited no change in number or weight of pups when compared with control, and losartan tended to diminish the rise in mean arterial pressure. In addition, the increase in urinary protein excretion was completely blocked by losartan. CONCLUSIONS: Endotoxin infusion in pregnant rats appears to be a suitable model for the study of preeclampsia. Moreover, the angiotensin II- dependent activation of an AT1 receptor appears to mediate a portion of the pathophysiologic features associated with preeclampsia.

Original languageEnglish (US)
Pages (from-to)1307-1312
Number of pages6
JournalAmerican Journal of Obstetrics and Gynecology
Volume178
Issue number6
DOIs
StatePublished - 1998
Externally publishedYes

Fingerprint

Angiotensin Type 1 Receptor
Pre-Eclampsia
Endotoxins
Angiotensin II
Losartan
Blood Vessels
Pregnancy
Thromboxanes
Vasoconstrictor Agents
Arterial Pressure
Blood Pressure
Weights and Measures
Thromboxane A2
Endothelins
Epoprostenol
Vasodilator Agents
Proteinuria
Dinoprostone
Arachidonic Acid
Sodium Chloride

Keywords

  • Angiotensin II
  • Hypertension
  • Losartan
  • Preeclampsia
  • Proteinuria

ASJC Scopus subject areas

  • Medicine(all)
  • Obstetrics and Gynecology

Cite this

The role of AT1 angiotensin receptor activation in the pathogenesis of preeclampsia. / Doering, T. P.; Haller, N. A.; Montgomery, M. A.; Freeman, E. J.; Hopkins, M. P.; Saade, George.

In: American Journal of Obstetrics and Gynecology, Vol. 178, No. 6, 1998, p. 1307-1312.

Research output: Contribution to journalArticle

Doering, T. P. ; Haller, N. A. ; Montgomery, M. A. ; Freeman, E. J. ; Hopkins, M. P. ; Saade, George. / The role of AT1 angiotensin receptor activation in the pathogenesis of preeclampsia. In: American Journal of Obstetrics and Gynecology. 1998 ; Vol. 178, No. 6. pp. 1307-1312.
@article{e136374975c14c22af06d8b578293055,
title = "The role of AT1 angiotensin receptor activation in the pathogenesis of preeclampsia",
abstract = "OBJECTIVES: Preeclampsia is characterized by an increase in vascular tone associated with reduced uteroplacental flow. The nature of hypertension arising in pregnancy suggests that the abnormal increase in blood pressure is dependent on some humoral factor that mediates vasospasm. There is evidence that preeclampsia results from a breakdown in the balance between vasodilators such as prostacyclin and prostaglandin E2 and nitric oxide and the vasoconstrictors angiotensin II, thromboxane A2, serotonin, and endothelin. Furthermore, vascular reactivity to angiotensin II is greatly enhanced in preeclampsia as opposed to normal pregnancies. The increased vascular tone and the enhanced thromboxane production noted in preeclampsia may be mediated by the increased sensitivity to angiotensin II because angiotensin II coupled to an AT1 receptor is a potent vasoconstrictor and stimulates the accumulation of free arachidonic acid, the precursor of thromboxane and the prostaglandins. STUDY DESIGN: We used a rat model that has been shown to express the relevant clinical features of human preeclampsia to investigate the involvement of the AT1 angiotensin receptor in this pathologic condition. Pregnant rats were divided into three groups that were either infused with saline or endotoxin on the 14th day of pregnancy. One of the endotoxin-infused groups was further treated with the AT1-selective antagonist losartan from day 11 until day 19 of pregnancy. RESULTS: Perinatal outcome, blood pressure, and urine protein were monitored for each group. We observed that endotoxin infusion resulted in a decrease in pup weight and number of pups and caused an increase in mean arterial pressure as well as increased proteinuria when compared with saline solution- infused animals. In contrast, endotoxin-infused rats receiving losartan exhibited no change in number or weight of pups when compared with control, and losartan tended to diminish the rise in mean arterial pressure. In addition, the increase in urinary protein excretion was completely blocked by losartan. CONCLUSIONS: Endotoxin infusion in pregnant rats appears to be a suitable model for the study of preeclampsia. Moreover, the angiotensin II- dependent activation of an AT1 receptor appears to mediate a portion of the pathophysiologic features associated with preeclampsia.",
keywords = "Angiotensin II, Hypertension, Losartan, Preeclampsia, Proteinuria",
author = "Doering, {T. P.} and Haller, {N. A.} and Montgomery, {M. A.} and Freeman, {E. J.} and Hopkins, {M. P.} and George Saade",
year = "1998",
doi = "10.1016/S0002-9378(98)70337-0",
language = "English (US)",
volume = "178",
pages = "1307--1312",
journal = "American Journal of Obstetrics and Gynecology",
issn = "0002-9378",
publisher = "Mosby Inc.",
number = "6",

}

TY - JOUR

T1 - The role of AT1 angiotensin receptor activation in the pathogenesis of preeclampsia

AU - Doering, T. P.

AU - Haller, N. A.

AU - Montgomery, M. A.

AU - Freeman, E. J.

AU - Hopkins, M. P.

AU - Saade, George

PY - 1998

Y1 - 1998

N2 - OBJECTIVES: Preeclampsia is characterized by an increase in vascular tone associated with reduced uteroplacental flow. The nature of hypertension arising in pregnancy suggests that the abnormal increase in blood pressure is dependent on some humoral factor that mediates vasospasm. There is evidence that preeclampsia results from a breakdown in the balance between vasodilators such as prostacyclin and prostaglandin E2 and nitric oxide and the vasoconstrictors angiotensin II, thromboxane A2, serotonin, and endothelin. Furthermore, vascular reactivity to angiotensin II is greatly enhanced in preeclampsia as opposed to normal pregnancies. The increased vascular tone and the enhanced thromboxane production noted in preeclampsia may be mediated by the increased sensitivity to angiotensin II because angiotensin II coupled to an AT1 receptor is a potent vasoconstrictor and stimulates the accumulation of free arachidonic acid, the precursor of thromboxane and the prostaglandins. STUDY DESIGN: We used a rat model that has been shown to express the relevant clinical features of human preeclampsia to investigate the involvement of the AT1 angiotensin receptor in this pathologic condition. Pregnant rats were divided into three groups that were either infused with saline or endotoxin on the 14th day of pregnancy. One of the endotoxin-infused groups was further treated with the AT1-selective antagonist losartan from day 11 until day 19 of pregnancy. RESULTS: Perinatal outcome, blood pressure, and urine protein were monitored for each group. We observed that endotoxin infusion resulted in a decrease in pup weight and number of pups and caused an increase in mean arterial pressure as well as increased proteinuria when compared with saline solution- infused animals. In contrast, endotoxin-infused rats receiving losartan exhibited no change in number or weight of pups when compared with control, and losartan tended to diminish the rise in mean arterial pressure. In addition, the increase in urinary protein excretion was completely blocked by losartan. CONCLUSIONS: Endotoxin infusion in pregnant rats appears to be a suitable model for the study of preeclampsia. Moreover, the angiotensin II- dependent activation of an AT1 receptor appears to mediate a portion of the pathophysiologic features associated with preeclampsia.

AB - OBJECTIVES: Preeclampsia is characterized by an increase in vascular tone associated with reduced uteroplacental flow. The nature of hypertension arising in pregnancy suggests that the abnormal increase in blood pressure is dependent on some humoral factor that mediates vasospasm. There is evidence that preeclampsia results from a breakdown in the balance between vasodilators such as prostacyclin and prostaglandin E2 and nitric oxide and the vasoconstrictors angiotensin II, thromboxane A2, serotonin, and endothelin. Furthermore, vascular reactivity to angiotensin II is greatly enhanced in preeclampsia as opposed to normal pregnancies. The increased vascular tone and the enhanced thromboxane production noted in preeclampsia may be mediated by the increased sensitivity to angiotensin II because angiotensin II coupled to an AT1 receptor is a potent vasoconstrictor and stimulates the accumulation of free arachidonic acid, the precursor of thromboxane and the prostaglandins. STUDY DESIGN: We used a rat model that has been shown to express the relevant clinical features of human preeclampsia to investigate the involvement of the AT1 angiotensin receptor in this pathologic condition. Pregnant rats were divided into three groups that were either infused with saline or endotoxin on the 14th day of pregnancy. One of the endotoxin-infused groups was further treated with the AT1-selective antagonist losartan from day 11 until day 19 of pregnancy. RESULTS: Perinatal outcome, blood pressure, and urine protein were monitored for each group. We observed that endotoxin infusion resulted in a decrease in pup weight and number of pups and caused an increase in mean arterial pressure as well as increased proteinuria when compared with saline solution- infused animals. In contrast, endotoxin-infused rats receiving losartan exhibited no change in number or weight of pups when compared with control, and losartan tended to diminish the rise in mean arterial pressure. In addition, the increase in urinary protein excretion was completely blocked by losartan. CONCLUSIONS: Endotoxin infusion in pregnant rats appears to be a suitable model for the study of preeclampsia. Moreover, the angiotensin II- dependent activation of an AT1 receptor appears to mediate a portion of the pathophysiologic features associated with preeclampsia.

KW - Angiotensin II

KW - Hypertension

KW - Losartan

KW - Preeclampsia

KW - Proteinuria

UR - http://www.scopus.com/inward/record.url?scp=0031595738&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031595738&partnerID=8YFLogxK

U2 - 10.1016/S0002-9378(98)70337-0

DO - 10.1016/S0002-9378(98)70337-0

M3 - Article

VL - 178

SP - 1307

EP - 1312

JO - American Journal of Obstetrics and Gynecology

JF - American Journal of Obstetrics and Gynecology

SN - 0002-9378

IS - 6

ER -